JRP
NKTR icon

Jasper Ridge Partners’s Nektar Therapeutics NKTR Stock Holding History

Jasper Ridge Partners’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,335
Closed -$220K – 93
2015
Q1 		$220K Hold
1,335
– – 0.02% 83
2014
Q4 		$310K Buy
+1,335
New +$285K 0.02% 71

Other funds holding NKTR

O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Jasper Ridge Partners's NKTR Position: Q2 2015 in Review

Jasper Ridge Partners sold out of Nektar Therapeutics (NKTR) in Q2 2015, closing a stake of 1,335 shares — an estimated $220K sold.

Jasper Ridge Partners first reported a position in NKTR in Q4 2014 and held it in 2 quarters. The position peaked at $310K in Q4 2014. 181 funds tracked by Wall St. Rank hold NKTR as of Q2 2015.

  • Jasper Ridge Partners reported no remaining Nektar Therapeutics position as of Q2 2015 after selling out during the quarter.
  • Jasper Ridge Partners sold 1,335 Nektar Therapeutics shares in Q2 2015, an estimated $220K.
  • Jasper Ridge Partners first reported a position in Nektar Therapeutics in Q4 2014 and held it in 2 quarters.
  • Jasper Ridge Partners's Nektar Therapeutics position peaked at $310K in Q4 2014.
  • 181 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2015.

Based on Jasper Ridge Partners's 13F filing for Q2 2015, filed 13 Aug 2015.